COEP Stock Analysis: Buy, Sell, or Hold?
COEP - Coeptis Therapeutics Holdings Inc. Common Stock
$13.86
0.25 (1.84%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When COEP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called COEP this week
83% bullish • 1 bearish
83% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: COEP shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: COEP shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: COEP is currently trading at $13.86, which is considered fair relative to its 30-day fair value range of $13.44 to $14.88.
Technical Outlook: Technically, COEP is showing sideways momentum. Immediate support is located at $11.25, while resistance sits at $14.69.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $3.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, COEP is showing sideways momentum. Immediate support is located at $11.25, while resistance sits at $14.69.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $3.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$13.44 -
$14.88
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 78.0% above Wall St target ($3.00)
Fair Price Analysis
30-Day Fair Range
$13.44 -
$14.88
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$11.25
Resistance Level
$14.69
Current Trend
Sideways
Fundamental Context
Wall Street Target
$3.00
(-78.0%)
Revenue Growth (YoY)
1563.7%
Last updated: January 31, 2026 3:02 PM ET
Data refreshes hourly during market hours. Next update: 4:02 PM
Data refreshes hourly during market hours. Next update: 4:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COEP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced COEP Option Strategies
Professional options setups generated by AI based on today's COEP price and gamma walls.
